Glycoprotein IIb/IIIa Receptor Inhibitors in Combination With Vorapaxar, a Platelet Thrombin Receptor Antagonist, Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes (from the TRACER Trial).

Glycoprotein IIb/IIIa Receptor Inhibitors in Combination With Vorapaxar, a Platelet Thrombin Receptor Antagonist, Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes (from the TRACER Trial). Am J Cardiol. 2015 May 15; 115(10):1325-32.

View in: PubMed

subject areas

Acute Coronary Syndrome
Aged
Cross-Over Studies
Dose-Response Relationship, Drug
Drug Therapy, Combination
Electrocardiography
Female
Follow-Up Studies
Humans
Lactones
Male
Middle Aged
Platelet Aggregation Inhibitors
Platelet Glycoprotein GPIIb-IIIa Complex
Pyridines
Receptors, Thrombin
Time Factors
Treatment Outcome

authors with profiles

Robert Harrington